Well, this is interesting:
https://bpspubs.onlinelibrary.wiley.com/doi/abs/10.1111/bph.15691
Our little Veyonda, not content with curing cancer and septic shock, looks like it can be used for Alzheimer’s too:
Conclusion and Implications
Our results strongly support the repurposing potential of SPA1413, which received a fast track status from the US-FDA for cancer treatment, targeting the anti-amyloidogenic and anti-neuroinflammatory activities for Alzheimer’s disease.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
9.8¢ |
Change
-0.007(6.67%) |
Mkt cap ! $28.63M | |||
| Open | High | Low | Value | Volume |
| 9.7¢ | 10.0¢ | 9.7¢ | $8.946K | 91.04K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 73788 | 9.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 108477 | 3 |
View Market Depth
| Last trade - 12.32pm 11/09/2025 (20 minute delay) ? |
| NOX (ASX) Chart |